CORT - Corcept Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CORT is currently covered by 4 analysts with an average price target of $99.8. This is a potential upside of $20 (25.06%) from yesterday's end of day stock price of $79.8.

Corcept Therapeutics's activity chart (see below) currently has 58 price targets and 78 ratings on display. The stock rating distribution of CORT is 2.94% HOLD and 97.06% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.19% with an average time for these price targets to be met of 256 days.

Highest price target for CORT is $145, Lowest price target is $131, average price target is $113.5.

Most recent stock forecast was given by EDWARD NASH from CANACCORD on 10-Sep-2025. First documented stock forecast 12-Oct-2015.

Currently out of the existing stock ratings of CORT, 1 are a HOLD (2.94%), 33 are a BUY (97.06%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$140

$67.13 (92.12%)

$142

8 days ago
(10-Sep-2025)

7/10 (70%)

$68.38 (95.48%)

290

Buy

$145

$72.13 (98.98%)

$150

4 months 12 days ago
(06-May-2025)

15/19 (78.95%)

$74.26 (104.98%)

134

Buy

$131

$58.13 (79.77%)

$78

5 months 15 days ago
(03-Apr-2025)

7/8 (87.5%)

$51.63 (65.05%)

86

Buy

$38

$13.94 (57.94%)

$29

1 years 10 months 12 days ago
(06-Nov-2023)

2/3 (66.67%)

$12.09 (46.66%)

37

Hold

$29

$-43.87 (-60.20%)

$26

2 years 1 months 15 days ago
(03-Aug-2023)

4/4 (100%)

$-2.24 (-7.17%)

262

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CORT (Corcept Therapeutics) average time for price targets to be met?

On average it took 256 days on average for the stock forecasts to be realized with a an average price target met ratio 91.19

Which analyst has the current highest performing score on CORT (Corcept Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on CORT (Corcept Therapeutics)?

Swayampakula Ramakanth has 5 price targets and 7 ratings on CORT

Which analyst is the currently most bullish on CORT (Corcept Therapeutics)?

Swayampakula Ramakanth with highest potential upside - $72.13

Which analyst is the currently most reserved on CORT (Corcept Therapeutics)?

David Buck with lowest potential downside - -$61.87

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?